Cytori Therapeutics

Cytori Therapeutics

Cytori Therapeutics

Developing cell therapies for significant medical conditions including hand scleroderma, knee osteoarthritis, thermal burns and stress urinary incontinence.
Founded
1996
Raised
$67.6M
Follow us
Alexa global traffic share
Twitter followers
16 Jun 2016
$17,100,000
Post-IPO equity

Cytori Closes Rights Offering for Gross Proceeds of $17.1 Million | Business Wire

businesswire
+1
08 Oct 2014
$13,500,000
Post-IPO equity
30 May 2014
$10,000,000
Post-IPO equity
01 Jul 2013
$27,000,000
Debt financing